Actinium Pharmaceuticals
ATNM
ATNM
42 hedge funds and large institutions have $7.11M invested in Actinium Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0.04% less ownership
Funds ownership: 0.33% → 0.29% (-0.04%)
Holders
42
Holding in Top 10
–
Calls
$180K
Puts
$7K
Top Buyers
| 1 | +$816K | |
| 2 | +$617K | |
| 3 | +$404K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$124K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$839K | |
| 3 | -$558K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$220K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$56.5K |